Literature DB >> 616838

The anorectic and hypotensive effect of fenfluramine in obesity.

K D Hudson.   

Abstract

A trial is reported of the hypotensive and anorectic effect of fenfluramine in general practice when combined with Yudkin's modification of the Marriott diet. The results confirm the anorectic effect and show that the maximum reduction of blood pressure occurs during the first four weeks of treatment.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 616838      PMCID： PMC2158263     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN： 0035-8797


  19 in total

1.  The treatment of obesity by the "highfat" diet. The inevitability of calories.

Authors:  J YUDKIN; M CAREY
Journal:  Lancet       Date:  1960-10-29       Impact factor: 79.321

2.  The cardiorespiratory syndrome of extreme obesity.

Authors:  G M BERLYNE
Journal:  Lancet       Date:  1958-11-01       Impact factor: 79.321

3.  Influence of obesity on morbidity and mortality.

Authors:  H H MARKS
Journal:  Bull N Y Acad Med       Date:  1960-05

4.  Illness in a summer holiday camp.

Authors:  R V Jones
Journal:  J R Coll Gen Pract       Date:  1976-08

5.  Chronic fenfluramine administration: some cerebral effects.

Authors:  S A Lewis; I Oswald; D L Dunleavy
Journal:  Br Med J       Date:  1971-07-10

6.  A survey of cliff falls and related accidents in the Torbay area, 1971-1973.

Authors:  B W Partridge
Journal:  Practitioner       Date:  1974-08

7.  A controlled investigation of the "glycolyptic" action of fenfluramine.

Authors:  J S Garrow; E A Belton; A Daniels
Journal:  Lancet       Date:  1972-09-16       Impact factor: 79.321

8.  Effect of fenfluramine on blood-lipids in man.

Authors:  G L Pawan
Journal:  Lancet       Date:  1969-03-08       Impact factor: 79.321

9.  Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial.

Authors:  H J Waal-Manning; F O Simpson
Journal:  Lancet       Date:  1969-12-27       Impact factor: 79.321

10.  Letter: Peripheral effects of anorectic drugs.

Authors:  L J Hipkin; J C Davis
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321
View more
  8 in total

1.  Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence.

Authors:  J McGuirk; R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.

Authors:  S C Bain; P M Dodson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 3.  Management strategies for weight control. Eating, exercise and behaviour.

Authors:  I D Caterson
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 4.  Obesity. Part II--Treatment.

Authors:  G A Bray; D S Gray
Journal:  West J Med       Date:  1988-11

Review 5.  Long-term efficacy of medical treatments of obesity.

Authors:  O I Linet
Journal:  Klin Wochenschr       Date:  1982-02-01

Review 6.  The role of drugs in the treatment of obesity.

Authors:  J G Douglas; J F Munro
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

7.  Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients.

Authors:  J Kolanowski; L T Younis; R Vanbutsele; J M Detry
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Pulmonary hypertension and fenfluramine.

Authors:  J G Douglas; J F Munro; A H Kitchin; A L Muir; A T Proudfoot
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.